Results

Total Results: 1,090 records

Showing results for "cardiovascular".
Users also searched for: statin

261. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/acs-depression/research-protocol
     June 01, 2021 - about exercise, which has been demonstrated to have beneficial effects for emotional health 23 and cardiovascular … Depression and cardiovascular disease: a clinical review. … MI, CHF Paroxetine Yes – Sertraline Yes – SNRIs Desvenlafaxine Yes Cardiovascular … Tricyclic antidepressants should be used with caution in patients with a history of cardiovascular disease … Oils"[Mesh] OR "Psychotherapy"[Mesh] OR "Exercise"[Mesh] OR "Physical Therapy Modalities"[Mesh] OR "Cardiovascular

262. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/angina-heart-attack-treatments/research-protocol
     December 01, 2019 - hospitalization for UA/NSTEMI and continued for long-term management has been shown to reduce future cardiovascular … or oral antiplatelet agents in patients undergoing percutaneous coronary intervention for improving cardiovascular … Resource utilization (e.g., emergency department visits) Final outcomes All-cause death Cardiovascular … Definition of Terms ACS acute coronary syndrome CV cardiovascular GP glycoprotein KQ key question … diseases"[MeSH Terms] OR ("cardiovascular"[tw] AND "diseases"[tw]) OR "heart diseases"[MeSH Terms] OR

263. Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/physical-activity-wheelchair/research
     May 01, 2024 - No studies reported long-term cardiovascular or metabolic disease health outcomes. … No studies reported long-term cardiovascular or metabolic disease health outcomes.

264. ¿Es la prueba para detectar el cáncer pulmonar apropiada para mí? | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/decision-aids/lung-cancer-screening/spanish
     March 01, 2021 - difficile Consumer Summary ARCHIVED Oct 30, 2017 Ácidos grasos omega-3 y la enfermedad cardiovascular

265. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - In the ACCORD trial, the addition of fenofibrate to simvastatin did not reduce the rates of cardiovascular … lead to superior lipid outcomes, but fails to reduce atherosclerosis or lead to decreased rates of cardiovascular … , the independent, unblinded Data Safety Monitoring Committee for the >18,000 patient IMPROVE-IT cardiovascular … LDL-c is an important factor in the development of atherosclerotic cardiovascular disease and higher … LDL-c is an important factor in the development of atherosclerotic cardiovascular disease and higher

266. The Empirical Evidence of Bias in Trials Measuring Treatment Differences | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/treatment-effects-bias/research
     November 01, 2017 - Protocol Nov 15, 2024 Dietary Intake of Polyunsaturated Fatty Acids and Plasma Lipid and Cardiovascular … Research Protocol Nov 15, 2024 Dietary Saturated Fat Replacement and Plasma Lipid and Cardiovascular

267. Contrast-Induced Nephropathy (CIN): Current State of the Evidence on Contrast Media and Prevention of CIN (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_clinician.pdf
     August 01, 2016 - administration) 18d 4194 ⬌ – 0.80 (0.64 to 1.01) ��� Need for renal replacement therapy e 5 1740 ⬌ – NR ��� Cardiovascular … events are included except CIN (e.g., hypersensitivity reactions, need for renal replacement therapy, cardiovascular … evidence to determine whether they prevent CIN, the SOE is often insufficient for other outcomes (e.g., cardiovascular

268. Systematic Review of Breastfeeding Programs and Policies, Breastfeeding Uptake, and Maternal Health Outcomes in Developed Countries (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/breastfeeding_research-protocol.pdf
     January 01, 2020 - addressed in the 2007 AHRQ review, including hypertension, rates of myocardial infarction and other cardiovascular … other reported harms) o KQ 2: Postpartum depression, breast cancer, ovarian cancer, osteoporosis, cardiovascular … Duration of lactation and risk factors for maternal cardiovascular disease. … Lactation and maternal measures of subclinical cardiovascular disease. … Criteria diabetes, hypertension, cardiovascular outcomes (e.g., stroke, myocardial infarction)

269. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non–ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/angina-heart-attack-treatments/research
     December 01, 2019 - Compared with clopidogrel, prasugrel reduced rates of cardiovascular death, myocardial infarction, or … results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular

270. Rapid Evidence Product_Nonemergent Percutaneous Coronary Intervention Versus Optimal Medical Treatment for Stable Ischemic Heart Disease: A Rapid Response Literature Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
     October 01, 2022 - Our primary outcomes of interest were major objective cardiovascular outcomes, including mortality, … Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. … Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med. … Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N Engl J Med. … Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N Engl J Med.

271. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - hospitalization for UA/NSTEMI and continued for long-term management has been shown to reduce future cardiovascular … or oral antiplatelet agents in patients undergoing percutaneous coronary intervention for improving cardiovascular … Cardiovascular disease-related death 3. Nonfatal MI 4. Revascularization 5. Stroke 6. … Definition of Terms ACS acute coronary syndrome CV cardiovascular GP glycoprotein KQ key question … diseases"[MeSH Terms] OR ("cardiovascular"[tw] AND "diseases"[tw]) OR "heart diseases"[MeSH Terms]

272. Comparative Effectiveness and Safety of Analgesics for Osteoarthritis – An Update to the 2006 Report | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/osteoarthritis-pain/research-protocol
     December 01, 2019 - to gastrointestinal bleeding, but they also appear to be associated with increased rates of serious cardiovascular … Demographic subgroups: age, sex, and race Coexisting diseases: cardiovascular conditions, such as hypertension … Cardiovascular: stroke, MI, CHF, hypertension and angina GI: perforations, symptomatic gastroduodenal … Outcomes will include improvements in osteoarthritis symptoms, cardiovascular and gastrointestinal adverse … including sex, age, ethnicity, diagnosis, comorbidities, concomitant medications, GI bleeding risk, cardiovascular

273. Linking Dental Services to Treatment Outcomes for Diabetes (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
     July 19, 2024 - CRP: C-reactive protein; CVD: Cardiovascular disease; E/e’ ratio: early diastolic mitral inflow velocity … outcomes suggesting potential cardiovascular benefits of periodontal therapy (high quality). … Moreover, the improvements in cardiovascular outcomes, such as the reduction in the E/e' ratio reported … Influence of Periodontal Disease on Cardiovascular Markers in Diabetes Mellitus Patients. … Periodontal Diseases and Cardiovascular Diseases, Diabetes, and Respiratory Diseases: Summary of the

274. Atrial-Fibrillation Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_executive.pdf
     June 01, 2013 - ); myocardial infarction; cardiovascular hospitalizations; heart failure symptoms; control of AF symptoms … mortality, cardiovascular hospitalizations, heart failure symptoms, control of AF symptoms, quality … Quality of life SOE = Insufficient (2 studies,135 patients) Note: CV = cardiovascular; KQ = Key Question … mortality, or other cardiovascular-related outcomes either in general patients with AF or in patients … Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study).

275. Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
     December 03, 2019 - Correct, the scope of the review is limited to 10 preventive services for cancer, cardiovascular disease … patients from all backgrounds are receiving evidence- based preventive services for individuals with cardiovascular

276. Linking Dental Services to Treatment Outcomes for Chronic Kidney Disease: A Rapid Response Review | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/treatment-outcomes-chronic-kidney/rapid-research
     October 01, 2024 - Additionally, CKD is increasing in prevalence faster than diabetes, cardiovascular disease, stroke and … and financial burdens. 13 Some studies suggest that periodontitis may also significantly exacerbate cardiovascular … Cardiovascular Risk Reduction with Periodontal Treatment in Patients on the Waiting List for Renal Transplantation … Intensive Periodontal Treatment Reduces Risks of Hospitalization for Cardiovascular Disease and All-Cause

277. Diagnosis and Management of Gout: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gout_clinician.pdf
     January 01, 2017 - swollen first metatarsophalangeal joint) and risk factors (hyperuricemia, male sex, hypertension, or >1 cardiovascular … liver function abnormalities, nausea, arthralgia, and rash �� Rare but serious adverse effects include cardiovascular … prophylactic agents should be considered (e.g., possible contraindications of NSAIDs in patients with cardiovascular

278. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0477_11-01-2011.pdf
     January 01, 2011 - Nonpharmacologic therapies: cardiovascular exercise; cognitive behavioral therapy (CBT); massage therapy

279. Zikmund (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/zikmund.pdf
     December 26, 2012 - • Gets result: o Your 10-­‐year risk of cardiovascular disease  is: 14.52% Slide  3: Robert’ … Slide  4: Question Is Robert  “informed” about his cardiovascular risk?

280. Home | AHRQ Effective Health Care Program (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/methodsguide_prepublication-draft_20120523.pdf
     August 10, 2017 - Jul. 25, 2017 Omega-3 Fatty Acids and Cardiovascular